A novel recombinant vaccine protecting mice against abrin intoxication

8Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Abrin toxin (AT) consisting of an A chain and a B chain is a potential agent for bioterrorism and an effective vaccine against AT poisoning is urgently required. In this study, AT B chain (ATB) was successfully expressed in the Escherichia coli (E. coli) and assessed the protection capacity against AT intoxication. The recombinant ATB (rATB) subunit induces a good immune response after 4 immunizations. All BALB/c mice immunized intraperitoneally (i.p.) with the purified rATB protein survived after challenged with 5 × LD50 of AT. Transfusion of sera from immunized mice provided passive protection in naive mice. Furthermore, histological findings showed that immunization with rATB decreased the severity of toxin-related tissue damage. This work indicates that the rATB protein may be a promising vaccine candidate against human exposure to AT.

Cite

CITATION STYLE

APA

Wang, J., Gao, S., Xin, W., Kang, L., Xu, N., Zhang, T., … Wang, J. (2015). A novel recombinant vaccine protecting mice against abrin intoxication. Human Vaccines and Immunotherapeutics, 11(6), 1361–1367. https://doi.org/10.1080/21645515.2015.1008879

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free